{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:08:30Z","timestamp":1770970110038,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1979,8,1]],"date-time":"1979-08-01T00:00:00Z","timestamp":302313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1979,8,1]],"date-time":"1979-08-01T00:00:00Z","timestamp":302313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1979,8]]},"DOI":"10.1136\/ard.38.4.356","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"356-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine."],"prefix":"10.1016","volume":"38","author":[{"given":"D.E","family":"Furst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J","family":"Clements","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.E","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0006-2952(67)90149-9","article-title":"The reduction of experimentally induced inflammation by sulfhydryl compounds","volume":"16","author":"Bailey, K.R.; Sheffner, A.L.","year":"1976","unstructured":"Bailey, K. R., and Sheffner, A. L. (1976). The reduction of experimentally induced inflammation by sulfhydryl compounds. Biochemical Pharmacology, 16, 1175-1182.","journal-title":"Biochemical Pharmacology"},{"key":"ref_2","article-title":"Acetylcysteine in the treatment of rheumatoid arthritis. Unpublished study Courtesy of Mead-Johnson Research Center","author":"Barley, J.P.; Vanal, M.E.","year":"1970","unstructured":"Barley, J. P., and Vanal, M. E. (1970). Acetylcysteine in the treatment of rheumatoid arthritis. Unpublished study Courtesy of Mead-Johnson Research Center."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/newbio231157a0","article-title":"N-acetylcysteine inactivates migration inhibition factor and delayed hypersensitivity reactions","volume":"231","author":"Bartfeld, H.; Ataynata, T.","year":"1971","unstructured":"Bartfeld, H., and Ataynata, T. (1971). N-acetylcysteine inactivates migration inhibition factor and delayed hypersensitivity reactions. Nature New Biology, 231, 157-158.","journal-title":"Nature New Biology"},{"key":"ref_4","first-page":"1398","article-title":"Failure of dimethyle sulfoxide in the treatment of scleroderma","volume":"1113","author":"Binnick, S.A.; Shore, S.S.; Corman, A.; Fleischmeyer, R.","year":"1977","unstructured":"Binnick, S. A., Shore, S. S., Corman, A., and Fleischmeyer, R. (1977). Failure of dimethyle sulfoxide in the treatment of scleroderma. Archives of Dermatology, 1113, 1398-1402.","journal-title":"Archives of Dermatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/art.1780210111","article-title":"Muscle disease in progressive systemic sclerosis","volume":"21","author":"Clements, P.J.; Furst, D.E.Campion; S., D.; Bohan, A.; Harris, R.; Levy, J.; Paulus, H.E.","year":"1978","unstructured":"Clements, P. J., Furst, D. E.. Campion, D. S., Bohan, A., Harris, R., Levy, J., and Paulus, H. E. (1978). Muscle disease in progressive systemic sclerosis. Arthritis and Rheumatism, 21, 62-71.","journal-title":"Arthritis and Rheumatism"},{"key":"ref_6","first-page":"1054","article-title":"Treatment of scleroderma","volume":"2","author":"D'Alacron-Sergovia, Ibanez; G.; Kershenobich, D.","year":"1974","unstructured":"D'Alacron-Sergovia, Ibanez, G., and Kershenobich, D. (1974). Treatment of scleroderma. Lancet, 2, 1054-1055.","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma)","volume":"46","author":"D'Angelo, W.A.; Fries, J.F.; Masi, A.T.; Shulman, L.E.","year":"1969","unstructured":"D'Angelo, W. A., Fries, J. F., Masi, A. T., and Shulman, L. E. (1969). Pathologic observations in systemic sclerosis (scleroderma). American Journal of Medicine, 46, 428-440.","journal-title":"American Journal of Medicine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.1780200805","article-title":"A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis","volume":"20","author":"Furst, D.E.; Levine, S.; Srinivasin, R.; Metzger, A.L.; Bangert, R.; Paulus, H.E.","year":"1977","unstructured":"Furst, D. E., Levine, S., Srinivasin, R., Metzger, A. L., Bangert, R., and Paulus, H. E. (1977). A double-blind trial of high versus conventional dosages of gold salts for rheumatoid arthritis. Arthritis and Rheumatism, 20, 1473-1480.","journal-title":"Arthritis and Rheumatism"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/rheumatology\/14.2.87","article-title":"Cutaneous extensibility in health and disease","volume":"14","author":"Grahame, R.; Harvey, W.","year":"1975","unstructured":"Grahame, R., and Harvey, W. (1975). Cutaneous extensibility in health and disease. Rheumatism and Rehabilitation, 14, 87-99.","journal-title":"Rheumatism and Rehabilitation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/art.1780200506","article-title":"Pulmonary function in scleroderma","volume":"20","author":"Guttadauria, M.; Ellman, H.; Emmanuel, G.; Kaplan, D.; Diamond, H.","year":"1977","unstructured":"Guttadauria, M., Ellman, H., Emmanuel, G., Kaplan, D., and Diamond, H. (1977). Pulmonary function in scleroderma. Arthritis and Rheumatism, 20, 1071-1079.","journal-title":"Arthritis and Rheumatism"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archderm.1968.01610120080013","article-title":"Generalised scleroderma treatment with an immunosuppressive agent","volume":"97","author":"Jansen, G.T.; Barraza, D.E.; Ballard, J.L.; Honeycutt, W.N.; Dillaha, C.J.","year":"1968","unstructured":"Jansen, G. T., Barraza, D. E., Ballard, J. L., Honeycutt, W. N., and Dillaha, C. J. (1968). Generalised scleroderma treatment with an immunosuppressive agent. Archives of Dermatology, 97, 690-698.","journal-title":"Archives of Dermatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1172\/JCI108455","article-title":"Lymphokine stimulation of collagen accumulation","volume":"58","author":"Johnson, R.L.; Ziff, M.","year":"1976","unstructured":"Johnson, R. L., and Ziff, M. (1976). Lymphokine stimulation of collagen accumulation. Journal of Clinical Investigation, 58, 240-252.","journal-title":"Journal of Clinical Investigation"},{"key":"ref_13","author":"Kondo, H.; Robin, B.S.; Rodnan, G.P.","year":"1976","unstructured":"Kondo, H., Robin, B. S., and Rodnan, G. P. (1976)."},{"key":"ref_14","first-page":"13881394","article-title":"Cutaneous antigen stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma)","volume":"58","unstructured":"Cutaneous antigen stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma). Journal of Clinical Investigation. 58, 13881394.","journal-title":"Journal of Clinical Investigation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03009747409165124","article-title":"An assessment of grip strength measurement in rheumatoid arthritis","volume":"3","author":"Lee, P.; Baxter, A.; Dick, W.C.; Webb, J.","year":"1974","unstructured":"Lee, P., Baxter, A., Dick, W. C., and Webb, J. (1974). An assessment of grip strength measurement in rheumatoid arthritis. Scandinavian Journal of Rheumatology, 3, 17-23.","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0026-0495(71)90120-X","article-title":"Sulfhydryl deficiency in connective tissue disorders: correlation with disease activity and protein alterations","volume":"20","author":"Lorber, A.; Bocy, R.A.; Chang, C.C.","year":"1970","unstructured":"Lorber, A., Bocy, R. A., and Chang, C. C. (1970). Sulfhydryl deficiency in connective tissue disorders: correlation with disease activity and protein alterations. Metabolism, 20, 446-455.","journal-title":"Metabolism"},{"key":"ref_17","article-title":"Effect of thiols in biological systems on protein sulphydryl content","volume":"19","author":"Lorber, A.; Chang, C.C.; Masuoka, D.; Meacham, I.","year":"1970","unstructured":"Lorber, A., Chang, C. C., Masuoka, D., and Meacham, I. (1970). Effect of thiols in biological systems on protein sulphydryl content. Biochemical Pharmacology, 19, 1551.","journal-title":"Biochemical Pharmacology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-73-2-317","article-title":"Vascular disease in progressive systemic sclerosis (scleroderma)","volume":"73","author":"Norton, W.L.; Nardo, J.M.","year":"1970","unstructured":"Norton, W. L., and Nardo, J. M. (1970). Vascular disease in progressive systemic sclerosis (scleroderma). Annals of Internal Medicine, 73, 317-324.","journal-title":"Annals of Internal Medicine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/art.1780190507","article-title":"Lymphocyte response to mitogens in progressive systemic sclerosis","volume":"19","author":"Salem, N.B.; Morse, J.H.","year":"1976","unstructured":"Salem, N. B., and Morse, J. H. (1976). Lymphocyte response to mitogens in progressive systemic sclerosis. Arthritis and Rheumatism, 19, 875-882.","journal-title":"Arthritis and Rheumatism"},{"key":"ref_20","first-page":"1001","article-title":"Progressive systemic sclerosis (diffuse scleroderma): a follow-up report of treatment with potaba","volume":"2","author":"Silver, W.; Gitlin, N.","year":"1973","unstructured":"Silver, W., and Gitlin, N. (1973). Progressive systemic sclerosis (diffuse scleroderma): a follow-up report of treatment with potaba. American Medical Journal, 2, 1001-1002.","journal-title":"American Medical Journal"},{"key":"ref_21","first-page":"74","article-title":"Chlorambucil therapy in progressive rheumatism. Arthritis and Rheumatism","volume":"1","author":"Steigerwald, J.C.","year":"1974","unstructured":"Steigerwald, J. C. (1974). Chlorambucil therapy in progressive rheumatism. Arthritis and Rheumatism. Suppl. 1, 74.","journal-title":"Suppl"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0002-9343(64)90162-7","article-title":"An early pulmonary physiologic abnormality in progressive systemic sclerosis (diffuse scleroderma)","volume":"36","author":"Wilson, R.J.; P., Rodnan-G.; Robin, E.D.","year":"1964","unstructured":"Wilson, R. J., Rodnan-G. P., and Robin, E. D. (1964). An early pulmonary physiologic abnormality in progressive systemic sclerosis (diffuse scleroderma). American Journal of Medicine, 36, 361-363.","journal-title":"American Journal of Medicine"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724142720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724142720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.38.4.356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T06:39:56Z","timestamp":1737527996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724142720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1979,8]]}},"alternative-id":["S0003496724142720"],"URL":"https:\/\/doi.org\/10.1136\/ard.38.4.356","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1979,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteine.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.38.4.356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1979 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}